RBC Capital Markets analyst Scott Heleniak continues to see shares of Fairfax Financial Holdings Ltd. (FFH-T, FFH.U-T) as “attractive at current levels” following “solid” fourth-quarter results that saw “one of the company’s better underwriting results in recent quarters as well as strong dividend and investment income.”
“Reserve releases were above normal in Q4 at a time when some peers are seeing weaker reserving while core margins remained healthy,” he added. “Overall premiums were down albeit this was impacted by a few large non-renewals. Affiliate income was lower than in recent quarters. Share buybacks picked up in Q4 and the company recently raised its annual dividend.”
On Thursday, the Toronto-based firm reported net earnings per share of US$52.87, which exceeded Mr. Heleniak’s US$30.70 net estimate. He estimated Fairfax earned US$31.15 per share on an operating basis versus his US$27.70 forecast, citing its combined ratio as the main source of the upside.
“Fairfax’s Q4 P&C combined ratio was 89.9 per cent, its best combined ratio all year,” he said. “Reserve development for the quarter (2.7 points) was above the recent run rate with OdysseyRe, Northbridge, and Zenith National each generating double-digit reserve releases. NWP declined 5.5 per cent due to non-renewals at Brit and OdysseyRe. Fairfax is still seeing mid-single-digit insurance rate increases in its insurance book, which we believe is still outpacing loss cost trends. On the Q4 call, the company refuted the Muddy Waters short report and specifically took time to defend their stance on topics such as their investment in Digit Insurance, valuation methods for Level III investments (specifically for Recipe, Exco, and Quest), third party transaction protocol, and IFRS 17. We thought management did a solid job of addressing these topics.”
Maintaining his 2024 forecast, Mr. Heleniak raised his 2025 net EPS estimate by US$2 to US$152.00, citing “slightly better” premium and combined ratio assumptions. That prompted him to raise his target for Fairfax shares to US$1,200 from US$1,085, maintaining an “outperform” rating. The average target on the Street is $1,744.76 (Canadian), according to LSEG data.
“We believe the new price target is warranted considering our constructive underwriting and net investment income outlook for 2024 and given favorable multiples for P&C insurers in the sector,” he said.
“Fairfax’s underwriting units continue to deliver impressive results and its investment portfolio has likewise begun delivering improving returns as some of its associate/affiliate holdings are monetized. We would look for these things to continue as Fairfax’s insurance companies are well positioned to capitalize on improved P&C pricing and have a track record of opportunistic growth in such environments. Our thesis is that Fairfax’s long-term track record of double-digit book value growth will continue and the current valuation provides an attractive risk-reward entry point for those willing to back the company’s long-term investment track record. Fairfax has a deep cash position and ample access to capital, which gives it the flexibility to be opportunistic as well as patient.”